|
US4021387A
(en)
|
1975-11-19 |
1977-05-03 |
President And Fellows Of Harvard College |
Eosinophilotactic tetrapeptides
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US4816449A
(en)
|
1984-08-09 |
1989-03-28 |
Immunetech Pharmaceuticals |
Immunotherapeutic anti-inflammatory peptide agents
|
|
US4613676A
(en)
|
1983-11-23 |
1986-09-23 |
Ciba-Geigy Corporation |
Substituted 5-amino-4-hydroxyvaleryl derivatives
|
|
ZA846192B
(en)
|
1984-08-09 |
1986-03-26 |
Merck Patent Gmbh |
Immunotherapeutic polypeptide agents
|
|
US5728680A
(en)
|
1987-12-30 |
1998-03-17 |
Cytoven J.V. |
Methods for normalizing numbers of lymphocytes
|
|
DK53291D0
(da)
|
1991-03-25 |
1991-03-25 |
Carlbiotech Ltd As |
Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
|
|
US5938117A
(en)
|
1991-04-24 |
1999-08-17 |
Aerogen, Inc. |
Methods and apparatus for dispensing liquids as an atomized spray
|
|
US6540154B1
(en)
|
1991-04-24 |
2003-04-01 |
Aerogen, Inc. |
Systems and methods for controlling fluid feed to an aerosol generator
|
|
US6629646B1
(en)
|
1991-04-24 |
2003-10-07 |
Aerogen, Inc. |
Droplet ejector with oscillating tapered aperture
|
|
US5277175A
(en)
|
1991-07-12 |
1994-01-11 |
Riggs John H |
Continuous flow nebulizer apparatus and method, having means maintaining a constant-level reservoir
|
|
GB9120005D0
(en)
|
1991-09-19 |
1991-11-06 |
Wellcome Found |
Method of administering phospholipid dispersions
|
|
US5355872B1
(en)
|
1992-03-04 |
1998-10-20 |
John H Riggs |
Low flow rate nebulizer apparatus and method of nebulization
|
|
US5284133A
(en)
|
1992-07-23 |
1994-02-08 |
Armstrong Pharmaceuticals, Inc. |
Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
|
|
US5329028A
(en)
|
1992-08-05 |
1994-07-12 |
Genentech, Inc. |
Carbohydrate-directed cross-linking reagents
|
|
JP4116072B2
(ja)
|
1992-08-27 |
2008-07-09 |
バイオクローンズ（プロプライエタリー）リミテッド |
逆向き、鏡像体および逆向き鏡像体合成ペプチド類似物
|
|
CA2150371C
(en)
|
1992-12-11 |
2002-09-17 |
Dov Borovsky |
Materials and methods for control of pests
|
|
US5559209A
(en)
|
1993-02-18 |
1996-09-24 |
The General Hospital Corporation |
Regulator regions of G proteins
|
|
US5497763A
(en)
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
|
AU6911896A
(en)
|
1995-09-06 |
1997-03-27 |
Steven L. Ryder |
Variable oxygen concentration high-flow nebulizer
|
|
US5823179A
(en)
|
1996-02-13 |
1998-10-20 |
1263152 Ontario Inc. |
Nebulizer apparatus and method
|
|
ES2140998B1
(es)
|
1996-05-13 |
2000-10-16 |
Univ Sevilla |
Procedimiento de atomizacion de liquidos.
|
|
US6126939A
(en)
|
1996-09-03 |
2000-10-03 |
Yeda Research And Development Co. Ltd. |
Anti-inflammatory dipeptide and pharmaceutical composition thereof
|
|
US6017735A
(en)
|
1997-01-23 |
2000-01-25 |
Marie Curie Cancer Care |
Materials and methods for intracellular transport and their uses
|
|
US20030113271A1
(en)
|
1997-01-29 |
2003-06-19 |
University Technology Corporation |
Formulations for pulmonary delivery
|
|
IT1291122B1
(it)
|
1997-03-28 |
1998-12-29 |
Sar Spa |
Micropompa per la nebulizzazione di fluidi con valvola dosatrice perfezionata
|
|
US6096707A
(en)
|
1997-07-11 |
2000-08-01 |
Biotie Therapies Ltd. |
Integrin binding peptide and use thereof
|
|
US6044841A
(en)
|
1997-08-29 |
2000-04-04 |
1263152 Ontario Inc. |
Breath actuated nebulizer with valve assembly having a relief piston
|
|
US6041776A
(en)
|
1998-05-14 |
2000-03-28 |
Briggs, Iii; Stephen W. |
Medical nebulization device
|
|
US6354516B1
(en)
|
1999-11-02 |
2002-03-12 |
Aradigm Corporation |
Pore structures for reduced pressure aerosolization
|
|
SE9900369D0
(sv)
|
1999-02-04 |
1999-02-04 |
Siemens Elema Ab |
Ultrasonic nebuliser
|
|
US6328030B1
(en)
|
1999-03-12 |
2001-12-11 |
Daniel E. Kidwell |
Nebulizer for ventilation system
|
|
EP1076091A1
(en)
*
|
1999-08-09 |
2001-02-14 |
Universite Catholique De Louvain |
Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds
|
|
US6968840B2
(en)
|
2000-05-05 |
2005-11-29 |
Aerogen, Inc. |
Methods and systems for operating an aerosol generator
|
|
WO2002009798A1
(en)
|
2000-08-02 |
2002-02-07 |
Research Development Foundation |
Jet nebulizer assembly for home administration of drugs in aerosols
|
|
US20020077283A1
(en)
|
2000-09-08 |
2002-06-20 |
Sessa William C. |
Caveolin peptides and their use as therapeutics
|
|
US6732944B2
(en)
|
2001-05-02 |
2004-05-11 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
|
GB0119852D0
(en)
|
2001-08-15 |
2001-10-10 |
Univ York |
Baculovirus
|
|
EP1471960B1
(en)
|
2002-01-07 |
2019-03-13 |
Novartis AG |
Devices for nebulizing fluids for inhalation
|
|
AU2003237798A1
(en)
|
2002-04-05 |
2003-10-27 |
Board Of Regents, The University Of Texas System |
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
|
|
EP1501479A1
(en)
|
2002-05-07 |
2005-02-02 |
Nektar Therapeutics |
Capsules for dry powder inhalers and methods of making and using same
|
|
US20040175384A1
(en)
|
2003-12-12 |
2004-09-09 |
Mohapatra Shyam S. |
Protein kinase C as a target for the treatment of respiratory syncytial virus
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20070207158A1
(en)
|
2003-06-17 |
2007-09-06 |
Harrison Roger G |
Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
US7625865B2
(en)
|
2004-03-26 |
2009-12-01 |
Universita Degli Studi Di Parma |
Insulin highly respirable microparticles
|
|
US8101726B2
(en)
|
2004-05-25 |
2012-01-24 |
Tactic Pharma, Llc |
Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy
|
|
AU2006249574B2
(en)
|
2005-05-25 |
2012-01-19 |
Novartis Ag |
Vibration systems and methods
|
|
TWI299993B
(en)
|
2005-12-15 |
2008-08-21 |
Dev Center Biotechnology |
Aqueous inhalation pharmaceutical composition
|
|
US8058227B2
(en)
|
2006-10-03 |
2011-11-15 |
Medical University Of South Carolina |
Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
|
|
US8487072B2
(en)
*
|
2006-10-19 |
2013-07-16 |
Angiochem Inc. |
Compounds for stimulating P-glycoprotein function and uses thereof
|
|
US20090068258A1
(en)
|
2007-08-28 |
2009-03-12 |
Lisanti Michael P |
Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy
|
|
EA201000785A1
(ru)
|
2007-12-13 |
2011-02-28 |
Глаксо Груп Лимитед |
Композиции для доставки в легкие
|
|
WO2009111625A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Board Of Regents, The University Of Texas System |
Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis
|
|
US20110171193A1
(en)
|
2008-06-12 |
2011-07-14 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating pulmonary hypertension
|
|
SG193209A1
(en)
|
2008-09-10 |
2013-09-30 |
Genentech Inc |
Methods for inhibiting ocular angiogenesis
|
|
AR074054A1
(es)
|
2008-10-21 |
2010-12-22 |
Baxter Healthcare Sa |
Formulaciones farmaceuticas de factor de von willebrand recombinante liofilizado
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
SG176053A1
(en)
|
2009-05-15 |
2011-12-29 |
Intermune Inc |
Methods of treating hiv patients with anti-fibrotics
|
|
JP2013505951A
(ja)
|
2009-09-28 |
2013-02-21 |
エフ．ホフマン−ラ ロシュ エルティーディー |
Ｃ型肝炎ウイルス複製の新規の大環状インヒビター
|
|
CN102753148B
(zh)
|
2010-02-11 |
2018-01-26 |
埃博灵克斯股份有限公司 |
用于制备气雾剂的方法和组合物
|
|
EP2635686B1
(en)
*
|
2010-11-05 |
2018-03-28 |
The Regents of The University of California |
Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
|
|
RU2014139546A
(ru)
|
2012-03-27 |
2016-05-20 |
Дженентек, Инк. |
Методы прогнозирования, диагностики и лечения идиопатического легочного фиброза
|
|
WO2013184482A1
(en)
|
2012-06-04 |
2013-12-12 |
Yale University |
Method of treating and preventing ocular angiogenesis
|
|
KR20180092324A
(ko)
|
2013-03-13 |
2018-08-20 |
포레스트 래보러토리즈 홀딩스 리미티드 |
미분화된 약제학적 조성물
|
|
PT3929207T
(pt)
|
2013-03-15 |
2024-10-21 |
Univ Texas |
Utilização do péptido fttftvt no tratamento de fibrose
|
|
CN104274827B
(zh)
|
2013-07-01 |
2020-07-14 |
上海贺普药业股份有限公司 |
贺普拉肽的制剂
|
|
CA2928759A1
(en)
|
2013-11-04 |
2015-05-07 |
Board Of Regents, The University Of Texas System |
Compositions and methods for administration of an enzyme to a subject's airway
|
|
US9908915B2
(en)
|
2013-11-26 |
2018-03-06 |
Yale University |
Cell-penetrating compositions and methods using same
|
|
ES2743622T3
(es)
*
|
2013-11-26 |
2020-02-20 |
E & B Tech Llc |
Tratamiento de la enfermedad autoinmune y/o inflamatoria usando moduladores de la caveolina novedosos
|
|
US20180050084A1
(en)
|
2015-02-27 |
2018-02-22 |
Board Of Regents, The University Of Texas System |
Polypeptide therapeutics and uses thereof
|
|
CN107216394B
(zh)
*
|
2017-06-21 |
2020-10-09 |
江南大学 |
一种小窝蛋白-1脚手架区融合多肽的制备方法及其应用
|
|
US20190224243A1
(en)
|
2018-01-25 |
2019-07-25 |
Musc Foundation For Research Development |
Enhancement of the Beneficial Effects of Mesenchymal Stem Cell Treatment by the Caveolin-1 Scaffolding Domain Peptide and Subdomains
|
|
EP3849580A4
(en)
|
2018-09-10 |
2022-06-15 |
Lung Therapeutics, Inc. |
Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
|
|
EP3849581A4
(en)
|
2018-09-10 |
2022-07-06 |
Board of Regents, The University of Texas System |
DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF
|
|
US20240082342A1
(en)
|
2018-11-21 |
2024-03-14 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for increasing lung cell viability
|
|
US20220370544A1
(en)
|
2018-11-21 |
2022-11-24 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for acute and chronic airway and alveolar diseases
|
|
US20220160814A1
(en)
|
2019-03-11 |
2022-05-26 |
Lung Therapeutics, Inc. |
Compositions and methods for protecting type 2 alveolar epithelial cells (aec2)
|
|
US12097222B2
(en)
|
2019-06-06 |
2024-09-24 |
Spiritus Therapeutics, Inc. |
Methods for attenuating viral infection and for treating lung injury
|
|
CN111671886B
(zh)
|
2020-03-05 |
2022-11-15 |
上海甘翼生物医药科技有限公司 |
一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途
|
|
US20230159608A1
(en)
|
2020-04-21 |
2023-05-25 |
Lung Therapeutics, Inc. |
Modified peptide fragments of cav-1 protein and uses thereof
|
|
EP4168031A4
(en)
|
2020-06-19 |
2024-07-10 |
Lung Therapeutics, LLC |
MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF PATHOGEN-INDUCED LUNG LESION
|
|
WO2022182949A2
(en)
|
2021-02-25 |
2022-09-01 |
Lung Therapeutics, Inc. |
Biomarkers for the treatment of interstitial lung disease
|
|
US12449810B2
(en)
|
2021-03-01 |
2025-10-21 |
The Boeing Company |
Autonomous maneuver generation to mate connectors
|
|
WO2022266410A1
(en)
|
2021-06-17 |
2022-12-22 |
Lung Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of post-acute covid-19
|
|
AU2022371643A1
(en)
|
2021-10-22 |
2024-05-02 |
Rein Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of chronic kidney disease
|